Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans.

@article{Khan2007UrotensinII,
  title={Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans.},
  author={Sohail Q. Khan and Sanjay Bhandari and Paulene Quinn and Joan E. Davies and Leong Loke Ng},
  journal={International journal of cardiology},
  year={2007},
  volume={117 3},
  pages={323-8}
}
BACKGROUND UII is elevated in patients with heart failure; however its role in acute myocardial infarction (AMI) is unknown. We sought to compare levels of UII in patients with AMI to controls. We also compared UII to N terminal pro B type natriuretic peptide (NT-BNP) to evaluate whether levels of UII can be used to predict the risk of adverse clinical outcome (ACO). METHODS AND RESULTS 129 patients were studied with serial blood measurements and echocardiogram during their index admission… CONTINUE READING